Salbutamol vs placebo
Mortality within the trial period · preterm infants (< 37 weeks GA) at risk of chronic lung disease
Summary of findings table ‐ Salbutamol showed no clear difference in mortality within the trial period compared with placebo (low certainty).
1 finding from 1 review
- Inhaled bronchodilators for the prevention and treatment of chronic lung disease in preterm infants 2024 · Cochrane Headline outcomes onlyRR 1.08 [0.5, 2.31]1 study · 173 participantsLow